Year |
Citation |
Score |
2023 |
Liu B, Gao S, Guo J, Kou F, Liu S, Zhang X, Wang X, Cao G, Chen H, Liu P, Xu H, Gao Q, Yang R, Zhu X. A Novel Nomogram for Predicting the Overall Survival in Patients with Unresectable HCC after TACE plus Hepatic Arterial Infusion Chemotherapy. Translational Oncology. 34: 101705. PMID 37257332 DOI: 10.1016/j.tranon.2023.101705 |
0.391 |
|
2022 |
Feng AW, Guo JH, Gao S, Kou FX, Liu SX, Liu P, Chen H, Wang XD, Xu HF, Cao G, Zhu X. A randomized phase II trial of hepatic arterial infusion of oxaliplatin plus raltitrexed versus oxaliplatin plus 5-fluorouracil for unresectable colorectal cancer liver metastases. Frontiers in Oncology. 12: 913017. PMID 36212504 DOI: 10.3389/fonc.2022.913017 |
0.361 |
|
2022 |
Cao G, Wang X, Chen H, Gao S, Guo J, Liu P, Xu H, Xu L, Zhu X, Yang R. Hepatic arterial infusion chemotherapy plus regorafenib in advanced colorectal cancer: a real-world retrospective study. Bmc Gastroenterology. 22: 328. PMID 35788189 DOI: 10.1186/s12876-022-02344-4 |
0.37 |
|
2022 |
Zheng K, Zhu X, Fu S, Cao G, Li WQ, Xu L, Chen H, Wu D, Yang R, Wang K, Liu W, Wang H, Bao Q, Liu M, Hao C, et al. Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial. Radiology. 211545. PMID 35103539 DOI: 10.1148/radiol.211545 |
0.398 |
|
2021 |
Liu BJ, Gao S, Zhu X, Guo JH, Kou FX, Liu SX, Zhang X, Wang XD, Cao G, Chen H, Liu P, Xu HF, Gao QZ, Yang RJ. Real-world study of hepatic artery infusion chemotherapy combined with anti-PD-1 immunotherapy and tyrosine kinase inhibitors for advanced hepatocellular carcinoma. Immunotherapy. PMID 34607482 DOI: 10.2217/imt-2021-0192 |
0.36 |
|
2021 |
Chen H, Nan G, Wei D, Zhai RY, Huang M, Yang WW, Xing BC, Zhu X, Xu HF, Wang XD, Zhang XY, Zhu BR, Liu P, Cao G, Gao S, et al. Hepatic artery injection of I-metuximab combined with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a prospective non-randomized, multicenter clinical trial. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 34475235 DOI: 10.2967/jnumed.121.262136 |
0.391 |
|
2021 |
Liu BJ, Gao S, Zhu X, Guo JH, Kou FX, Liu SX, Zhang X, Wang XD, Cao G, Chen H, Liu P, Zhu LZ, Xu HF, Yang RJ. Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis. Biomed Research International. 2021: 6670367. PMID 34337041 DOI: 10.1155/2021/6670367 |
0.404 |
|
2020 |
Guo JH, Liu SX, Gao S, Kou FX, Zhang X, Wu D, Li XT, Chen H, Wang XD, Liu P, Zhang PJ, Xu HF, Cao G, Zhu LZ, Yang RJ, et al. Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma. World Journal of Gastroenterology. 26: 3975-3988. PMID 32774071 DOI: 10.3748/wjg.v26.i27.3975 |
0.379 |
|
2020 |
Liu BJ, Gao S, Zhu X, Guo JH, Zhang X, Chen H, Wang XD, Yang RJ. Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinoma. World Journal of Gastrointestinal Oncology. 12: 663-676. PMID 32699581 DOI: 10.4251/wjgo.v12.i6.663 |
0.388 |
|
2019 |
Liu B, Zhu X, Gao S, Guo J, Wang X, Cao G, Zhu L, Liu P, Xu H, Chen H, Zhang X, Liu S, Kou F. Safety and efficacy of hepatic arterial infusion chemotherapy with raltitrexed and oxaliplatin post-transarterial chemoembolization for unresectable hepatocellular carcinoma. Journal of Interventional Medicine. 2: 91-96. PMID 34805879 DOI: 10.1016/j.jimed.2019.07.006 |
0.388 |
|
2018 |
Zhang HY, Guo JH, Gao S, Chen H, Wang XD, Zhang PJ, Liu P, Cao G, Xu HF, Zhu LZ, Yang RJ, Li J, Zhu X. Effect of primary tumor side on survival outcomes in metastatic colorectal cancer patients after hepatic arterial infusion chemotherapy. World Journal of Gastrointestinal Oncology. 10: 431-438. PMID 30487954 DOI: 10.4251/wjgo.v10.i11.431 |
0.359 |
|
2017 |
Wang X, Yarmohammadi H, Cao G, Ji X, Hu J, Yarmohammadi H, Chen H, Zhu X, Yang R, Solomon SB. Dual phase cone-beam computed tomography in detecting <3 cm hepatocellular carcinomas during transarterial chemoembolization. Journal of Cancer Research and Therapeutics. 13: 38-43. PMID 28508831 DOI: 10.4103/0973-1482.206242 |
0.304 |
|
2017 |
Zhang H, Guo J, Gao S, Zhang P, Chen H, Wang X, Li X, Zhu X. Prognostic factors for transarterial chemoembolization combined with sustained oxaliplatin-based hepatic arterial infusion chemotherapy of colorectal cancer liver metastasis. Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu. 29: 36-44. PMID 28373752 DOI: 10.21147/j.issn.1000-9604.2017.01.05 |
0.382 |
|
2017 |
Guo JH, Zhang HY, Gao S, Zhang PJ, Li XT, Chen H, Wang XD, Zhu X. Hepatic artery infusion with raltitrexed or 5-fluorouracil for colorectal cancer liver metastasis. World Journal of Gastroenterology. 23: 1406-1411. PMID 28293087 DOI: 10.3748/wjg.v23.i8.1406 |
0.354 |
|
2016 |
Wang X, Hu J, Cao G, Zhu X, Cui Y, Ji X, Li X, Yang R, Chen H, Xu H, Liu P, Li J, Li J, Hao C, Xing B, et al. Phase II Study of Hepatic Arterial Infusion Chemotherapy with Oxaliplatin and 5-Fluorouracil for Advanced Perihilar Cholangiocarcinoma. Radiology. 160572. PMID 27820684 DOI: 10.1148/radiol.2016160572 |
0.349 |
|
2015 |
Chen H, Zhang J, Cao G, Liu P, Xu H, Wang X, Zhu X, Gao S, Guo J, Zhu L, Zhang P. Target hepatic artery regional chemotherapy and bevacizumab perfusion in liver metastatic colorectal cancer after failure of first-line or second-line systemic chemotherapy. Anti-Cancer Drugs. PMID 26566233 DOI: 10.1097/CAD.0000000000000290 |
0.369 |
|
2014 |
Cao G, Zhu X, Li J, Shen L, Yang R, Chen H, Wang X, Gao S, Xu H, Zhu L, Liu P, Guo J. A comparative study between Embosphere(®) and conventional transcatheter arterial chemoembolization for treatment of unresectable liver metastasis from GIST. Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu. 26: 124-31. PMID 24653635 DOI: 10.3978/j.issn.1000-9604.2014.02.11 |
0.387 |
|
2014 |
Chen H, Liu P, Xu HF, Wang XD, Zhu X, Gao S, Cao G, Zhu LZ, Guo JH. Low-dose, short-interval target vessel regional chemotherapy through the hepatic artery combined with transarterial embolization in gastric cancer patients with liver metastases after failure of first-line or second-line chemotherapy: a preliminary analysis. Anti-Cancer Drugs. 25: 92-100. PMID 24185381 DOI: 10.1097/CAD.0000000000000027 |
0.384 |
|
Show low-probability matches. |